Xizang Haisco Pharmaceutical Group Co Ltd (002653) — Net Asset Momentum
Xizang Haisco Pharmaceutical Group Co Ltd (002653) recorded a net asset momentum of 2.0% as of December 2025, with net assets of CN¥4.29 Billion CNY. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See shareholders equity of Xizang Haisco Pharmaceutical Group Co Lt for net asset value and shareholders' equity analysis.
YoY Momentum
Current Net Assets
Years of Data
Country
Xizang Haisco Pharmaceutical Group Co Ltd Net Asset Momentum (2008–2025)
This chart tracks Xizang Haisco Pharmaceutical Group Co Ltd's year-over-year net asset growth across 18 annual reporting periods from 2008 to 2025. The most recent momentum reading is +2.0%, with net assets of CN¥4.29 Billion CNY as of December 2025. For live market cap and overall valuation, see Xizang Haisco Pharmaceutical Group Co Lt stock valuation.
Annual Net Asset History for Xizang Haisco Pharmaceutical Group Co Ltd (2008–2025)
The table below shows the complete annual net asset history for Xizang Haisco Pharmaceutical Group Co Ltd from 2008 to 2025, covering 18 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. Check 002653 tangible net assets ratio to evaluate the tangible quality of the company's equity base.
| Year | Net Assets (CNY) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | CN¥4.29 Billion | CN¥7.01 Billion | CN¥2.72 Billion | ▲ +2.0% |
| 2024 | CN¥4.20 Billion | CN¥6.80 Billion | CN¥2.60 Billion | ▲ +0.8% |
| 2023 | CN¥4.17 Billion | CN¥6.65 Billion | CN¥2.48 Billion | ▲ +33.1% |
| 2022 | CN¥3.13 Billion | CN¥6.05 Billion | CN¥2.91 Billion | ▲ +7.3% |
| 2021 | CN¥2.92 Billion | CN¥5.01 Billion | CN¥2.09 Billion | ▲ +2.3% |
| 2020 | CN¥2.85 Billion | CN¥5.00 Billion | CN¥2.15 Billion | ▲ +20.1% |
| 2019 | CN¥2.38 Billion | CN¥5.04 Billion | CN¥2.66 Billion | ▲ +19.2% |
| 2018 | CN¥1.99 Billion | CN¥4.37 Billion | CN¥2.37 Billion | ▲ +1.2% |
| 2017 | CN¥1.97 Billion | CN¥4.11 Billion | CN¥2.14 Billion | ▼ -12.2% |
| 2016 | CN¥2.25 Billion | CN¥3.74 Billion | CN¥1.50 Billion | ▲ +4.1% |
| 2015 | CN¥2.16 Billion | CN¥3.23 Billion | CN¥1.07 Billion | ▲ +2.3% |
| 2014 | CN¥2.11 Billion | CN¥2.87 Billion | CN¥767.55 Million | ▲ +9.4% |
| 2013 | CN¥1.93 Billion | CN¥2.46 Billion | CN¥530.24 Million | ▲ +12.8% |
| 2012 | CN¥1.71 Billion | CN¥1.95 Billion | CN¥238.49 Million | ▲ +122.4% |
| 2011 | CN¥767.76 Million | CN¥882.70 Million | CN¥114.95 Million | ▲ +69.4% |
| 2010 | CN¥453.09 Million | CN¥629.88 Million | CN¥176.79 Million | ▲ +235.2% |
| 2009 | CN¥135.17 Million | CN¥349.39 Million | CN¥214.22 Million | ▼ -37.1% |
| 2008 | CN¥214.95 Million | CN¥353.69 Million | CN¥138.73 Million | — |